Environmental carcinogens of the polycyclic aromatic hydrocarbon class, such as benzo(a)pyrene, are metabolized by cellular enzyme systems to highly reactive bay-region diol epoxides which have been identified as ultimate carcinogens. These compounds modify macromolecules in cells, thereby initiating the process of carcinogenesis. Although the interactions of benzo(a)pyrene diol epoxide (BPDE-I) with DNA have been studied in vitro, little is known of how this relates to interactions which take place in cellular nuclei, where the DNA is intimately associated with a variety of chromosomal proteins. Even less is known of the interactions of BPDE-I with these proteins, nor of how such interactions may affect the regulation of gene expression which involves interactions between DNA control regions and trans-acting proteins. In the present proposal, several model systems will be studied in which a particular DNA-binding protein and its target DNA can be prepared in large amounts utilizing recombinant DNA technology. The systems include the interaction of histone proteins with DNA, the interaction of the human transcription factor Sp1 with the promoter of the aprt gene, the interaction of yeast transaction factor SW15 with its target DNA in the HO gene, and the interaction of the Xenopus transcription factor TFIIIA with the internal control region of the 5S RNA gene. The latter three are all examples of zinc-finger transcription factors, which appear to be of widespread importance. The following questions will be asked of these systems: 1) In nucleosomal complexes of the histones with DNA, where are DNA binding sites for BPDE-I located? 2) How does binding of the protein to its target DNA affect the formation of covalent BPDE-I DNA adducts? 3) Does BPDE-I bind covalently to the transcription factors? If so, what are the target amino acid residues and how is this binding affected by interaction with the target DNA sequence? 4) What is the effect of BPDE-I-DNA adduct formation in a target sequence upon the subsequent interaction with its cognate transcription factor?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA035581-11
Application #
2088997
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1983-08-01
Project End
1996-02-29
Budget Start
1994-03-01
Budget End
1996-02-29
Support Year
11
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Internal Medicine/Medicine
Type
Organized Research Units
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Wang, Aijin; Gu, Jing; Judson-Kremer, Kimberly et al. (2003) Response of human mammary epithelial cells to DNA damage induced by BPDE: involvement of novel regulatory pathways. Carcinogenesis 24:225-34
Wang, A; Johnson, D G; MacLeod, M C (2001) Molecular cloning and characterization of a novel mouse epidermal differentiation gene and its promoter. Genomics 73:284-90
Pietrasanta, L I; Smith, B L; MacLeod, M C (2000) A novel approach for analyzing the structure of DNA modified by Benzo[a]pyrene diol epoxide at single-molecule resolution. Chem Res Toxicol 13:351-5
Wang, A; Pierce, A; Judson-Kremer, K et al. (1999) Rapid analysis of gene expression (RAGE) facilitates universal expression profiling. Nucleic Acids Res 27:4609-18
Butler, A P; Johnson, D G; Kumar, A P et al. (1997) Disruption of transcription in vitro and gene expression in vivo by DNA adducts derived from a benzo[a]pyrene diol epoxide located in heterologous sequences. Carcinogenesis 18:239-44
MacLeod, M C (1996) A possible role in chemical carcinogenesis for epigenetic, heritable changes in gene expression. Mol Carcinog 15:241-50
MacLeod, M C; Johnston, D A; LaBate, M et al. (1996) The probability of occurrence of oligomer motifs in the human genome and genomic microheterogeneity. J Theor Biol 181:311-8
MacLeod, M C; Powell, K L; Kuzmin, V A et al. (1996) Interference of benzo[a]pyrene diol epoxide-deoxyguanosine adducts in a GC box with binding of the transcription factor Sp1. Mol Carcinog 16:44-52
MacLeod, M C (1995) Interaction of bulky chemical carcinogens with DNA in chromatin. Carcinogenesis 16:2009-14
MacLeod, M C; Powell, K L; Tran, N (1995) Binding of the transcription factor, Sp1, to non-target sites in DNA modified by benzo[a]pyrene diol epoxide. Carcinogenesis 16:975-83

Showing the most recent 10 out of 24 publications